Guinea-Bissau police seized vaccines from a controversial trial that anti-vaccine official RFK Jr. tried to fund, highlighting a clash between public health ethics and political influence.
AI-generated summary. Check the original reporting for context and accuracy.
Source excerpt
This is the available feed excerpt, which may be shortened or in the publisher’s original language.
Police in Guinea-Bissau raided the offices of Danish researchers on Monday, seizing doses of hepatitis B vaccine intended for a vaccine trial for newborns. International health experts have called the trial "unethical," but anti-vaccine Health Secretary Robert F. Kennedy Jr. has attempted to fund it with US taxpayer dollars. Under Kennedy, the US Centers for Disease Control and Prevention announced in December that it had awarded the Danish researchers—led by married couple Peter Aaby and Christine Stabell Benn of Bandim Health Project—an unsolicited $1.6 million grant to run the trial. Aaby and Stabell Benn are controversial vaccine researchers who claim vaccines cause overlooked harms. They have been repeatedly praised by Kennedy, but are currently under investigation for alleged scientific misconduct by Danish authorities. Plans for the trial were halted in January as widespread condemnation erupted over the trial's design, which would potentially expose thousands of newborns in the country to hepatitis B, risking a lifelong infection that can lead to liver cirrhosis, cancer, and premature death. Outrage flared again after a Rolling Stone story earlier this month claimed the CDC set aside another $1.6 million in funding in late September and planned to move forward with the trial.Read full article Comments
About priority
An automated sorting aid based on source trust, keywords, and entities, on a scale of 1–12. High: 9–12; medium: 6–8; low: 1–5. It does not measure urgency, verify reporting, or indicate editorial endorsement.
Europe faces a critical dilemma where expanding AI data centers threatens climate goals, forcing policymakers to balance technological growth against environmental commitments.